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Interview
In the Tradition of Science: An Interview with Victor
Ambros
Jane Gitschier*
Department of Medicine and Pediatrics, University of California San Francisco, San Francisco, California, United States of America
I was on shaky footing with RNA
interference (RNAi) and microRNAs
(miRNAs), and I knew I had to do
something about it. As the number of
miRNAs in humans escalated and I tried
to sort through the twists and turns of the
compelling story of their discovery, I
turned to a colleague for insight. ‘‘Inter-
view Victor Ambros,’’ he said, and I took
his advice.
For those of you who might also benefit
from a little primer on the topic, RNAi is a
well-established phenomenon of using
double-stranding RNA to effect gene
silencing, and it flourished as an investi-
gative tool years before its connection to
the tiny endogenous miRNAs was made.
RNAi had been first recognized in plants
as a response to infections, and the cellular
machinery, such as Argonaut and Dicer,
to effect RNAi had also emerged. But
these advances had been made without
appreciating the cellular fleet of stealth
molecules—miRNAs—that had piloted
under our radar, scanning and tempering
our genome.
I asked Victor Ambros to fill me in on
some of these discoveries, moments he
shared with his wife Rosalind and his long-
term scientific collaborator and friend,
Gary Ruvkun. After I had to abort plans
to visit Victor in Massachusetts, we
eventually settled on a Skype interview,
and I persuaded him to shoot his own
photo on his computer’s photo booth
(Image 1). We had a grainy connection
but a lot of fun.
Victor grew up on a small farm in
Vermont, his father and mother having
made the commitment to a rural life,
where they set about raising a family of
eight children. He went to MIT for
undergrad, grad, and post-doctoral work,
ventured down Massachusetts Avenue to
Harvard for his first job, and managed to
slip out of state to Dartmouth for his
second. He then returned to the Boston
area where he has now settled in at the
University of Massachusetts, Worcester.
Gitschier: What do you think fun-
neled you into a career in science?
Ambros: I’m not sure. My earliest
recollection was that I dreamed of being a
baseball player. But that was until about
age 8 or 9. After that, I can’t recall not
wanting to be a scientist, and I must trace
it to reading books that were lying around
the house.
I just got intrigued by the tradition of
doing science. I read a book about famous
inventors and books about astronomers,
and decided I wanted to be an astrono-
mer. These were plans and dreams that
just sort of came together without any kind
of authentic, realistic experience. Just a
child reading books and deciding that’s
what he wanted to do. It seemed like it was
a wonderful tradition to be part of—that
tradition of scientists and inventors.
Somebody got me a toy telescope when
I was young, and I became an amateur
astronomer when I was 11 or 12. I built a
telescope out of a book. My father
encouraged me an awful lot. He was
excited that I was interested in science
and he would help me with building
projects.
Gitschier: He was a hands-on kind of
a guy.
Ambros: Yeah, my dad is exceedingly
clever. I’d say he is a brilliant man who,
because he was born at the wrong time in
Europe—in Poland—was caught up in
World War II. He went to high school
only for a year or so because the schools
closed down at the onset of the war. He
became essentially a fugitive from the
Russians and Germans in Poland. He
was captured by the Germans and spent
the rest of the War as a forced laborer. He
spent from the age of 15 to 19 having no
education at all.
When he was liberated by the American
army, he worked for the army as an aide
to some army officers, and he was exposed
to a lot of books in the mansions of the ex-
German rich folk, which were being used
by the American army as headquarters.
That’s how he began to teach himself
English.
By the time I was born, in 1953, I came
to know my dad as someone who was very,
very clever, could build almost anything,
and was very well-read. It was fun to listen
to him talk about books that he had read,
and even today we recommend books to
each other and discuss them. He speaks
four or five languages. My dad is someone
whom I admire enormously, especially
because I felt that he was someone who
had missed an opportunity to be a
formally educated person, but he still
made a great life for himself and his
family.
I remember from a very young age
being very conscious of pleasing my dad
because of the contrast between what I felt
I had, which were all sorts of opportuni-
ties, and the opportunities that he missed.
So that would help keep me on track—
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study hard, because after all, that’ll please
Dad. So he was a very important person
for me throughout my childhood and high
school. He still is!
Gitschier: Do you mind if I just follow
up a little bit more? When you said he was
in a forced labor camp, do you mean he
was in one of the concentration camps?
Ambros: He’s not Jewish; he was
Catholic, so he was lucky enough not to
be categorically sent to death. He was also
able-bodied, so he became incorporated
into this system of forced labor that they
had in Germany. It was very much like
American slavery. People were property.
They were essentially rented out or leased
to others who were doing work for the
government. So my dad became property
of the German government, and he
worked for a company that processed
wood into fuel for trucks.
Gitschier: What happened to his
siblings and his parents?
Ambros: Well, his mom and dad had
already died when he was still a child. But
he had a sister. He lost track of her during
the war, but they were reunited in 1960.
The Red Cross had a system of registering
displaced persons. Eventually names were
matched up but it took some years—this
was pre-computers. They did not know
that the other had survived the war.
She came over here and lived near us
until she died just last year.
Gitschier: Do you think you’ve stayed
in New England all these years because of
the proximity to your family?
Ambros: Yeah, I would say so. I like
New England, and it is nice to be within
striking distance. But I did go to MIT, not
because it is in New England, but because
it was the place I wanted to go to school.
We ended up being dug in, in Boston.
Also, I’m a person who does like the
familiar. Given a choice, I would stay.
Gitschier: Let’s move on to some of
these major discoveries that you’ve made.
And let’s start with your being in Horvitz’s
lab and working on these things called
heterochronic mutants.
Ambros: The term heterochrony re-
ferred to a mode of developmental change
in evolution, where animals would acquire
some change in the relative timing of
events, and that would lead to changes in
morphology. The classic example is the
axolotl, in which the adults retain their
gills instead of going through the meta-
morphosis. Stephen Jay Gould had written
extensively about these in his columns in
the Natural History magazine. When Bob
and I started studying the mutants that
had primarily changes in the relative
timing of events, we thought it would be
cool to co-opt that term to describe the
mutants, since the term was already there.
Bob had set up this group at MIT that
was bringing a really interesting approach,
I thought, to this worm, which was to
isolate mutants that were defective in egg
laying. And Bob’s brilliant insight was that
there are so many different ways that a
worm could be defective in this behavior
of egg laying that it allows access to all
kinds of processes and pathways in the
animal. A worm can fail to lay eggs
because it’s missing the apparatus and
those would include all sorts of develop-
mental mutants, and from that came the
heterochronic mutants, which are the
developmental timing mutants that lead
to morphological problems in egg laying,
and all the signaling mutants, the Ras
pathway.
Gitschier: But he couldn’t have
known at the time that there was going
to be a Ras-pathway mutant.
Ambros: It’s hard to know what Bob
actually anticipated. I think that he
anticipated more than we give him credit
for—whether it was Ras or FGF [fibro-
blast growth factor] or you name it, he
knew that the animal was developing with
enormous precision. Cells were talking to
each other and neurons were connecting
with muscles. So he got mutants in mu-
scles, nerves, neurotransmitters, develop-
ment, cell lineages, etc. So actually, these
heterochronic mutants were a small subset
of a whole series of different classes of
mutants that were coming out of those
egg-laying screens.
So he assigned the project to me to look
at the first of these, which was lin-4, and
another gene called unc-86. But I didn’t
really get any traction with unc-86.
lin-4 was the gene that I actually made
some progress on, and that was because
suppressors of lin-4 arose spontaneously.
One of the first was isolated by Chip
Ferguson, who was in the lab at the time.
Chip gave this mutant to me and said this
mutant suppresses lin-4, and it turned out
to be a mutation in lin-14.
That made the link between lin-4 and
lin-14, and my contribution was to find
some dominant mutations in lin-14 that
had the same phenotype as lin-4. So, the
loss of function in lin-4 was equivalent in
phenotype to a gain-of-function mutation
in lin-14. And then we did some epistasis
work and decided that a parsimonious
scenario was that lin-4 repressed lin-14.
Then Gary Ruvkun came to Bob’s lab.
He was a molecular biologist, and nobody
in the lab was doing molecular biology. So
Gary taught us how to make DNA and do
restriction digests. Gary and I collaborated
on trying to clone lin-14. We made some
progress, and we eventually published a
paper showing that we had cloned lin-14,
without including a sequence! In those
days you could get a publication by
demonstrating that you had identified a
band on a Southern and a piece of cloned
probe that represented the gene.
Then Gary focused on the lin-14 project
in his lab at MGH [Massachusetts General
Hospital] and I and I took the lin-4 project
to my lab at Harvard.
Gitschier: I know that you and Gary
are very close. Was it part of the design
that you were going to stay physically close
together in the Boston area?
Ambros: No, that was just accidental.
And splitting up the genes was a good
idea. In those days, cloning a gene wasn’t
that straightforward. You didn’t have a
genome sequence. We were cloning genes
purely based on mutation. Transformation
rescue hadn’t been established yet. Each of
us started in our labs in ’84…
Gitschier: It was almost a decade then
before….[you published on lin-4]…
Ambros: [Laughter] Yeah. Well, we
had lots of other projects. What was done
in my lab was driven by the interests of the
students and the post-docs.
Also, lin-4 was a tough project because
there was only one mutation. Even though
Bob had been screening and screening for
egg-laying defective mutants, and lin-4 was
an egg-laying defective mutant, there was
only one allele!
Gitschier: In retrospect, do you think
that told you that it was going to be a
really small gene?
Ambros: Well, we had lots of con-
cerns. There were categories of concerns.
One would be that it was a peculiar
mutation, called E912. E means it was
identified in England in [Sydney] Bren-
ner’s lab, it was actually induced by 32P
degeneration. John Sulston had been
making 32P-labeled worms for doing Cot
curves, and a member of the lab screened
the progeny of those animals for mutations
and ended up getting E912.
So, we were concerned that maybe it’s a
peculiar kind of [DNA] rearrangement
that fuses this thing to that thing in some
way and has what’s called ‘‘neomorphic’’
activity. So you might be cloning a locus
that in retrospect might not really tell you
anything about the normal function of
either of the respective genes.
Gitschier: Did that kind of concern
make it a back burner project?
Ambros: Exactly. To clone these
genes, we like to proceed by getting
multiple mutations, so that when we get
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to the gene, we’ll be able to identify these
mutations.
It really wasn’t until my wife, Rosalind
Lee, joined the lab, which I think was in
1987, that this really seemed like a perfect
project for a research assistant. She was a
technician and her career didn’t depend
on this. She came to try to move along the
genetic experiments we were doing to find
the locus.
And then Rhonda Feinbaum joined the
lab as a post-doc. Rhonda was interested
in the project, especially as this would be a
team effort between her and Rosalind; it
wouldn’t be all on one person’s shoulders.
And over the course of 4 years, the two of
them ended up, by dividing up the effort,
putting together that story which we ended
up publishing in 1993.
Rosalind [known to her friends and
colleagues as Candy] did the positional
cloning, mapping lin-4 with respect to
recombinant chromosomes between two
worm strains, and eventually found the
DNA lesion associated with the lin-4
mutation using Southern blotting. And it
turned out it, the lesion proved to be a
deletion and rearrangement, consistent
with a 32P degeneration.
Rhonda did complementation rescue
experiments, and she and Candy togeth-
er made the constructs and whittled the
gene down. At some point we recognized
that the gene product couldn’t be a
conventional protein-coding gene be-
cause we narrowed it down to what
looked like an intron of a protein-coding
gene. We were able to get rescue of the
mutant phenotype fully with just the
little piece of DNA—about 700 base
pairs.
In parallel, Rhonda also did a very
massive screen for new alleles and picked
up one new allele, and that turned out to
be really useful. This was a point mutation
affecting a single nucleotide of the
miRNA. It was the lynchpin supporting
the conclusion that that the small RNA
was the lin-4 gene product.
Gitschier: By the time you figured this
all out, it was what, 1991 or ’92?
Ambros: Yes, more or less. We wrote
this down somewhere! We knew the basic
story for almost a year before we pub-
lished. There was a year or so where our
lab and Gary Ruvkun’s lab were cleaning
up loose ends and putting together a nice
pair of complementary papers.
The importance of that relationship
with Gary’s lab was that Gary was
pursuing an analysis of gain-of-function
mutations in lin-14. Those dominant
mutations that were causing lin-14 to be
essentially constitutively expressed devel-
opmentally and de-repressed from lin-4
activity were in the 39 UTR.
Gary had cloned a gene from another
nematode species and did RNA alignments
to try to identify conserved sequences that
may be important. He was developing a
hypothesis that the 39 UTR was a site
where the lin-4 gene product would bind.
So it became really important to find out
what the lin-4 gene product was.
We anticipated that the stories would
converge, so we were staying in touch.
When Rhonda and Rosalind were zeroing
in on this small piece of DNA and showing
ultimately that the transcript from that
region was really short—the main tran-
script was only 21 or 22 nucleotides. At
that point we shared the sequence with
Gary because he said, ‘‘We have sequenc-
es from these two species, and we should
line them up and see whether there is
some sort of anti-sense base pairing.’’
It was actually pretty obvious once we
did the alignment that there had to be anti-
sense base pairing. lin-4 matched the lin-14
39 UTR in several places, and all of those
places were conserved between the two
species. And Candy had shown that lin-4
was conserved between those species, as
well, so here we had a little, well-conserved
RNA, and the complementarity to lin-14
was conserved. That was really cool.
Gitschier: Were you feeling pressure
from Gary to get this lin-4?
Ambros: I’m sure there was a healthy
competitive component there. I was think-
ing, ‘‘Well this matters to somebody else,
so we really need to push it forward.’’
Gitschier: Sounds more collaborative,
though, than competitive.
Ambros: Well, from my perspective
the competitive aspect was [that] you
wanted to do at least a good a job as
Gary was doing in his part. The pressure
was: you don’t want to get your part
wrong! It was very nice that the sharing of
the data and looking at the RNA sequence
together came from a desire to make sure
that the experience was a good one—good
for me and for him. I didn’t want to be the
one who missed it when he got it. And I
didn’t want to be the one who got it if he
missed it, because that wouldn’t feel right
either. So we said, we’ll exchange se-
quences and we’ll look at it together.
Gitschier: Were you on the phone
while you were both looking at it?
Ambros: We sent the sequences to
each other and said let’s look at this and
call back this evening and see what we see.
So we called and said, ‘‘Do you see it?’’
‘‘Yes, I see it!’’
Gitschier: That must have been really
exciting.
Ambros: It was. And it felt good. That
we had found something and that we had
found it together.
Gitschier: OK, now let’s talk briefly
about RNAi and how you eventually
realized that lin-4 fitted into that story.
Ambros: The phenomenon of RNAi
had been described and studied in plants
before Fire and Mello had hit on this
double-stranded RNA [dsRNA] trigger
concept in 1999. So it was already known
that this phenomenon in plants and
animals seemed to smell the same—an
epigenetic gene silencing mechanism.
That didn’t immediately help us appre-
ciate miRNAs. We had found lin-4 in 1993,
and even though we showed it formed a
dsRNA precursor, we didn’t connect that
to dsRNA-based phenomenon called RNAi
that Fire and Mello found.
Gitschier: Because at that time, the
RNAi people were talking about things
that were brought in to the cell.
Ambros: That’s right. At that point, it
was a mysterious capacity for the animal
to respond. So it wasn’t clear what this
represented in terms of endogenous mech-
anisms. The animal was too good at it for
it not to be deeply important. And then
there were a rapid series of discoveries,
where Mello, in one of his important
contributions that helped win the [Nobel]
Prize for him, was finding Argonaut—that
there were these conserved proteins that
were required for the silencing in worms.
But, it wasn’t until David Baulcombe
found that the silencing process in plants
involved the formation of very short—
about 22-25 nucleotides—dsRNAs, that
indicated that in plants, and probably by
implication in animals, that the long
double-stranded RNA precursor was be-
ing processed to a short molecule.
And I remember seeing that result and
thinking, ‘‘Hmm, that looks a lot like
lin-4.’’
The point of the story I’m going to tell
you now is how interesting it is that we—at
least I—was so resistant to a new idea. We
thought that lin-4 could be just specific to
worms, because Candy had actually tried to
find lin-4 molecules in other species and
couldn’t find them. And now we know that
this little RNA isn’t conserved well enough
to detect by hybridization.
So, Baulcombe has found this stuff in
plants and it’s associated with RNAi. So
maybe this helps explain how lin-4 bio-
genesis works; it must be that it has co-
opted the RNAi machinery to be pro-
cessed. So, you see what I’m saying—not
that lin-4 represented some broad class of
things…
Gitschier:… that were fundamental.
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Ambros: Yeah. Maybe it’s just a
special case of how a system can co-opt
the RNAi machinery to make a gene
product that is a small RNA product.
And it wasn’t until finally Gary found
let-7 in C. elegans, with a sequence com-
pletely different from lin-4, that [we
realized] in nematodes the same thing
had evolved twice. But personally, it didn’t
trigger me to think that lin-4 and let-7 must
be part of something very broad and
conserved in all animals. Still, in my mind
it was a special nematode thing.
Until Gary published his Nature paper in
2000 showing that let-7 was conserved in
sequence in all these animals—sea ur-
chins, mammals… And that was a total
revelation. It was a watershed discovery
that made me instantly go from a pessimist
to an optimist. I said to myself that there
must be more small RNAs like lin-4 and
let-7, and in other animals. It was really
exciting. To open that Nature and say,
‘‘Holy cow! The way I’ve been looking at
things is totally wrong.’’
Gitschier: Didn’t you know about
Gary’s work before the paper came out?
Ambros: He kept it secret! It was really
cool.
Gitschier: I loved what you said in the
Lasker Award commentary [in Nature
Medicine] that after reading their paper
you literally had to sit down for 10 minutes
and look out the window to reorder your
view of the universe.
Ambros: Right, so Candy and I
immediately started cloning those things,
and we were very naı¨ve; we thought we
were the only ones doing it. That was
another adventure.
Gitschier: Actually, that was another
thing I liked about both your and Gary’s
commentaries. It was just so great the way
you referred to your spouses as being
important contributors to the work. I was
touched.
Ambros: I think that what Gary and I
were trying to get at, independently, was
the question of what’s the point, really, of
an award, like the Lasker Award? Basical-
ly, I feel lucky to be there, because if it
weren’t for a whole lot of stuff that I did
not control, the award wouldn’t have
happened. If I hadn’t happened to work
in David Baltimore’s lab, I probably
wouldn’t have been noticed by Bob
Horvitz, and if I hadn’t been in Bob
Horvitz’s lab, I wouldn’t have even
worked on this system. And, if Candy
hadn’t come to work in the lab, none of
this project would have happened. And, if
my father hadn’t encouraged me… It just
gets out of control if you think about what
can lead to a moment like getting an
award.
And so it has very little to do, frankly,
with the particular person getting the
award. What the award represents is a
process that involves interactions amongst
many, many people. And the end, one
person ends up getting the award. It’s
really important to try to acknowledge that
and understand the fact that really every-
thing that happens in science, including
the discoveries that people try to acknowl-
edge by awards, are really the products of
this confluence of people’s histories and
people’s interactions. I really believe that
science gets done by people with average
abilities and talents, for the most part, and
when something special happens, enough
so that people want to acknowledge it
with an award, it was really…in large
part…luck!
We try to say to the public, here’s an
award for somebody who’s really, really
special. But actually, it’s not the somebody
who is really special, it’s the science that is
special. The way we do science, and the
way it works is so amazing. I wish non-
scientists would better understand this.
That science is a community exercise, that
it involves people interacting, that it
involves a lot of good fortune in the
context of people trying to do something
really carefully and following curiosity.
That’s why it works so well!
You’re preaching to the choir, but
the idea is that science remains fun and
it is a tremendous adventure. It’s great
that you do these columns because it
reminds people of why we all do science.
It’s through the stories that we are
reminded.
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